• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

The 5-year survival rate for people with cancerous brain or CNS tumors is 34 percent for men and 36 percent for women.7 GE Healthcare’s technology helps to improve visualization and analytical monitoring of disease progression or response to therapy.8

References:

7. https://www.cancer.net/cancer-types/brain-tumor/statistics

8. https://www.gehealthcare.com/en/products/advanced-visualization/all-applications/pet-vcar
JB04823XX